Smart Watches In Health Care - Publications - Faculty & Research

February 2022 (Revised February 2024)
Case

Sekisui House and the In-Home Early Detection Platform

To address an aging population and sales declines, a major Japanese homebuilder considers pivoting to provide and support an in-home health detection platform, in competition with tech companies. This case considers the point of view of major builders regarding how... View Details

Keywords: Voice Assistants; Architecture; Smart Home; Aging Society; Digitalization; Real Estate; Home Automation; Sensors; Strategy; Digital Platforms; Health Care and Treatment; Housing; Age; Health Industry; Health Industry; Health Industry; Japan

Citation

Educators

Purchase

January 2017 (Revised March 2021)
Case

Fitbit

By: Regina E. Herzlinger, Christine Snively and Sarah Mehta

In 2019, Fitbit lost its leadership in the wearable sensor market to Apple and to cheaper alternatives.
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details

Keywords: Wearable Sensors; Smart Watches In Health Care; Google Acquisition; Health Care and Treatment; Information Technology; Acquisition

Citation

Educators

Purchase

Article

Effects of Description of Options on Parental Perinatal Decision-Making

By: Marlyse F. Haward, Leslie K. John, John M. Lorenz and Baruch Fischhoff

Objective: To examine whether parents' delivery room management decisions for extremely preterm infants are influenced by (a) the degree of detail with which options-comfort care (CC) or intensive care (IC)-are presented or (b) their order of presentation. Methods: 309... View Details

Keywords: Decision Making; Values and Beliefs; Personal Characteristics; Attitudes; Motivation and Incentives; Family and Family Relationships; Health Care and Treatment

Citation

Find at Harvard

November 2005 (Revised November 2005)
Case

Massachusetts General Hospital and the Enbrel Royalty

By: David S. Scharfstein and Darren R. Smart

Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well... View Details